Cleared Traditional

K955021 - QUANTA LITE PR3 (FDA 510(k) Clearance)

Mar 1996
Decision
138d
Days
Class 2
Risk

K955021 is an FDA 510(k) clearance for the QUANTA LITE PR3. This device is classified as a Test System, Antineutrophil Cytoplasmic Antibodies (anca) (Class II - Special Controls, product code MOB).

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on March 19, 1996, 138 days after receiving the submission on November 2, 1995.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K955021 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 02, 1995
Decision Date March 19, 1996
Days to Decision 138 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code MOB — Test System, Antineutrophil Cytoplasmic Antibodies (anca)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660